Granix Injection, Solution
Product Images NDC 63459-920
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 58 technical images submitted to the FDA as part of the official labeling for Granix (NDC 63459-920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cephalon, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ifu Image 2 (Image 10)
Ifu Image 3 (Image 11)
Ifu Image 4 (Image 12)
Ifu Image 5 (Image 13)
Ifu Image 6 (Image 14)
Ifu Image 7 (Image 15)
This appears to be an image or diagram with instructions on how to align the top edge of a stopper to a dosage fill line. It seems to be related to measuring or administering medicine. However, without further context or information, it is unclear what specific product or device this is related to.*
Ifu Image 8 (Image 16)
Ifu Image 9 (Image 17)
Ifu Image 10 (Image 18)
Ifu Image 11 (Image 19)
Image 2
Ifu Image 12 (Image 20)
Ifu Image 13 (Image 21)
Ifu Image 14 (Image 22)
Ifu Image 15 (Image 23)
Ifu Image 16 (Image 24)
Ifu Image 17 (Image 25)
Ifu Image 18 (Image 26)
Ifu Image 19 (Image 27)
Ifu Image 20 (Image 28)
Ifu Image 21 (Image 29)
Image 3
Ifu Image 22 (Image 30)
Ifu Image 23 (Image 31)
Ifu Image 24 (Image 32)
Ifu Image 25 (Image 33)
Ifu Image 26 (Image 34)
Ifu Image 27 (Image 35)
Ifu Image 28 (Image 36)
Ifu Image 29 (Image 37)
Teva Oncology Logo 3 (Image 38)
Granix® (tbo-filgrastim) Injection 300 Mcg/0.5ml With Safety Needle Guard, 1s Carton (Image 39)
Image 4
Granix® (tbo-filgrastim) Injection 300 Mcg/0.5ml Without Safety Needle Guard, 1s Carton, Part 1 Of 2 (Image 40)
Granix® (tbo-filgrastim) Injection 300 Mcg/0.5ml Without Safety Needle Guard, 1s Carton, Part 2 Of 2 (Image 41)
Granix® (tbo-filgrastim) Injection 480 Mcg/0.8ml With Safety Needle Guard, 1s Carton (Image 42)
Granix® (tbo-filgrastim) Injection 480 Mcg/0.8ml Without Safety Needle Guard, 1s Carton, Part 1 Of 2 (Image 43)
Granix® (tbo-filgrastim) Injection 480 Mcg/0.8ml Without Safety Needle Guard, 1s Carton, Part 2 Of 2 (Image 44)
Image 45
Image 46
The text describes an image with the title "BODY FRONT BODY BACK". The image appears to show a silhouette of a person with labels pointing to different areas of the body including the stomach area, buttocks, and thighs. The first word "Uppee" appears to be a misspelling of "Upper" but its context is not clear from the given text.*
Image 47
Image 48
Image 49
Image 5
Image 50
Image 51
Image 52
Image 53
Granix® is an injection consisting of the recombinant Granulocyte-Colony Stimulating Factor (G-CSF) derived from E. coli. It is used only for subcutaneous usage and is prepared in a single-dose pre-filled syringe with a needle guard for safety. The text also includes several unrelated and random characters and numbers that could not be interpreted into a meaningful description.*
Image 54
Image 55
Granix is an injection medication that contains Granulocyte Colony-Stimulating Factor (GCSF), which is used to increase the production of white blood cells in patients receiving cancer treatment. It is administered subcutaneously with a single-dose pre-filled syringe with a safety needle guard. The medication comes as a 480mcg/0.8mL solution and is intended for use by healthcare professionals only. The text also includes some unintelligible characters, likely due to poor .*
Image 56
Image 57
Image 58
Image 6
Image 7
Image 8
Image 9
This text appears to be a description of the available dose and number of syringes for a medication. The text mentions the size and number of the syringes provided, as well as the presence of medication in each syringe. It also provides instructions on removing the cap to adjust the medication to match a prescribed dose.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.